Your browser doesn't support javascript.
loading
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.
García-Sanz, Ramón; Corchete, Luis Antonio; Alcoceba, Miguel; Chillon, María Carmen; Jiménez, Cristina; Prieto, Isabel; García-Álvarez, María; Puig, Noemi; Rapado, Immaculada; Barrio, Santiago; Oriol, Albert; Blanchard, María Jesús; de la Rubia, Javier; Martínez, Rafael; Lahuerta, Juan José; González Díaz, Marcos; Mateos, María Victoria; San Miguel, Jesús Fernando; Martínez-López, Joaquín; Sarasquete, María Eugenia.
Affiliation
  • García-Sanz R; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • Corchete LA; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • Alcoceba M; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • Chillon MC; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • Jiménez C; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • Prieto I; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • García-Álvarez M; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • Puig N; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • Rapado I; Hospital 12 de Octubre, Madrid, Spain.
  • Barrio S; Hospital 12 de Octubre, Madrid, Spain.
  • Oriol A; Hospital Germans Trias i Pujol, Badalona, Spain.
  • Blanchard MJ; Hospital Universitario Ramón y Cajal de Madrid, Madrid, Spain.
  • de la Rubia J; Hospital Dr Peset de Valencia, Valencia, Spain.
  • Martínez R; Hospital Clínico de San Carlos de Madrid, Madrid, Spain.
  • Lahuerta JJ; Hospital 12 de Octubre, Madrid, Spain.
  • González Díaz M; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • Mateos MV; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
  • San Miguel JF; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, Pamplona, Spain.
  • Martínez-López J; Hospital 12 de Octubre, Madrid, Spain.
  • Sarasquete ME; Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.
Hematol Oncol ; 35(4): 746-751, 2017 Dec.
Article in En | MEDLINE | ID: mdl-27605156
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Peripheral Nervous System Diseases / Multiple Myeloma Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Hematol Oncol Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Peripheral Nervous System Diseases / Multiple Myeloma Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Hematol Oncol Year: 2017 Document type: Article